GlaxoSmithKline, Pfizer to create over-the-counter drug giant
The two drugmakers are merging their healthcare divisions, bringing together brands such as Sensodyne and Advil
Watch CBS News
The two drugmakers are merging their healthcare divisions, bringing together brands such as Sensodyne and Advil
The drugmaker's chief operating officer will take the leadership role on January 1
Pfizer recalled some children's Advil because the measuring cup was marked in teaspoons, not milliliters
To help in the short-term, the FDA and EpiPen manufacturer Pfizer are extending expiration dates for certain injectors that are expiring or close to expiring
Another generic version of the EpiPen won't come soon enough for users of life-saving medicine that's had manufacturing issues since May
Years after seeking federal approval, Israeli drugmaker gets nod to sell version of life-saving allergy treatment
Pfizer says it will "return these prices to their pre-July 1 levels as soon as technically possible"
The president says drugmakers "should be ashamed" of raising costs "for no reason," causing share prices to slip
Move comes just weeks after President Trump said drug companies would be making "voluntary, massive drops in prices"
Chronic supply disruptions of some of the most basic treatments are another reason U.S. health care is so expensive
President Trump said high U.S. drug prices subsidize the rest of the world, and demanded making other nations pay more
As many as 400 patients have been unable to fill EpiPen prescriptions since May 2, according to reports
The generic versions of the little blue pill will likely be cheaper than brand-name Viagra for most men
While the pharmaceutical industry has been taking heat lately over pricing, some companies still stand to do well
Regulators call the epilepsy drug’s price increase -- as much as 2,600 percent – “excessive and unfair”
These names emerged from screens that Morningstar uses to cull the top dividend payers that are attractively priced
Company had been talking about a split for several years, thinking that two companies might grow faster than one
Medivation focuses on developing medicines for cancer and serious diseases with few treatment options
Drug company's buying spree could be harbinger of more deals to come, according to at least one market observer
Cancer drug maker Medivation jumped 20 percent after Pfizer announced it would buy the company for $14 billion
Deal speeds Pfizer on path to be key player in cancer drug sector, its chairman and CEO says
Doctors Without Borders says pneumonia vaccine in Greece costs 20 times what it does in other countries
As concerns mount about addiction, pharma giant says it wants to help address public health concern
Anacor's stock soared more than 53 percent in Monday premarket trading; deal is expected to close in the third quarter
Human rights groups says 25 FDA-approved drugmakers have now restricted their products from being used in executions